Companies‎ > ‎US Research‎ > ‎

Agilent Technologies (NYSE: A) | Company Profile, History, Competitors




Agilent Technologies (NYSE: A) provides diagnostic tools, consumables, services and software for the laboratory industry. The company was formed in 1999 as a spin off of Hewlett Packard.

Agilent provides tools for use in laboratories. These include Mass Spectrometry devices, Chromatography tools and diagnostic equipment. The company was founded in 1999 when Hewlett-Packard spun off their Medical Products division. At the time, it was the largest IPO in technology.

Business Overview

Agilent operates in three main segments:
  • Life Sciences and Applied Markets (49% of 2017 Revenues): Sells instruments and related software for Mass Spectrometry, Liquid Chromatography, Gas Chromatography, Spectroscopy and software.
  • Agilent CrossLab (34% of 2017 Revenues): Provides instrument servicing for laboratories to manage their resources.
  • Diagnostics and Genomics (17% of 2017 Revenues): Sells equipment and software for clinical and diagnostic labs.

Life Sciences and Applied Markets Segment

LSAG is Agilent's largest segment. Agilent sells instruments and related software for Mass Spectrometry (MS), Liquid Chromatography (LC), Gas Chromatography (GC), Spectroscopy & Vacuum, and Software & Informatics. These technologies are routinely used in testing of food safety, monitoring, water supply testing, discovery and development of drugs. Agilent has 23,000 total customers.

Agilent CrossLab Segment

Agilent provides instrument servicing regardless of the manufacturer, and software to help laboratories manage their resources. Agilent's asset management and data analytics capabilities helps laboratories better track instrument utilization and manage overall costs. Agilent has 43,000 total customers.

Diagnostics and Genomics Segment

Agilent sells reagents, instruments, software and consumables for the clinical and diagnostics labs. Diagnostics and Genomics segment is made up of three primary product categories: Dako (pathology instrumentation), Genomics (arrays, sample prep), Nucleic Acid Solutions (synthetic nucleic acids). Agilent has 14,000 total customers.

Management

Michael McMullen (CEO): Michael McMullen serves as CEO since 2015. Prior, he held various roles at Agilent, including COO, SVP Chemical Analysis, and Manager China & Japan.

Didier Hirsch (CFO): Didier Hirsch serves as CFO since 2010. Prior, he served in various roles at Agilent, including VP Tax, Chief Accounting Officer, and Controller. He has also worked at Hewlett-Packard.

Financials

 $ USD in millions     2013     2014  2015  2016  2017
 Revenues  $3,894  $4,048  $4,038  $4,202  $4,472 
 Gross Profit  $1,907  $2,072   $1,997   $2,005   $2,063 
 Operating Profit  $386  $419   $522   $615   $841 
 Net Income $734  $549  $401   $462   $684 
 EPS $2.15  $1.65  $1.20  $1.42  $2.12